Continental Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cannae Holdings
CNNE
|
+$2.77M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$2.28M |
| 3 |
Alerian MLP ETF
AMLP
|
+$1.34M |
| 4 |
Uber
UBER
|
+$1.2M |
| 5 |
Cardinal Health
CAH
|
+$1.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.87M |
| 2 |
Gilead Sciences
GILD
|
+$1.69M |
| 3 |
Tenet Healthcare
THC
|
+$1.18M |
| 4 |
Wells Fargo
WFC
|
+$1.02M |
| 5 |
Kroger
KR
|
+$924K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.12% |
| 2 | Healthcare | 18.51% |
| 3 | Consumer Staples | 2.93% |
| 4 | Industrials | 2.36% |
| 5 | Consumer Discretionary | 2.02% |
Similar funds
Continental Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Continental Advisors held 67 positions worth $236M, up 8.6% from $217M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Continental Advisors deployed $21.5M of net new capital in Q3 2021, opening 10 new positions and adding to 19 existing holdings. Its largest new stake was Lakefront Biotherapeutics American Depositary Shares: 10,000 shares worth $526K.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was Pfizer, an estimated $1.87M trimmed.
- Continental Advisors's largest Q3 2021 buy was Lakefront Biotherapeutics American Depositary Shares: 10,000 shares worth $526K.
- Continental Advisors added most to Cannae Holdings in Q3 2021, an estimated $2.77M increase.
- Continental Advisors's biggest Q3 2021 reduction was Pfizer, cutting an estimated $1.87M.
- Continental Advisors fully exited SANTANDER CONSUMER USA HOLDINGS INC in Q3 2021, selling an estimated $833K.
- Continental Advisors's ten largest holdings make up 40% of its $236M portfolio in Q3 2021.
- Continental Advisors opened 10 new positions and closed 3 in Q3 2021.
- Continental Advisors's portfolio value rose 8.6% quarter-over-quarter to $236M.
Based on Continental Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.